Dr. Natalia Perez de la Ossa, MD PhD Vascular Neurologist, Coordinator of the Stroke Unit Hospital Germans Trias i Pujol, Barcelona, and director of the Catalan Stroke Plan. Badalona, Barcelona, Spain Dr. Pérez de la Ossa is a stroke neurology, head of the Stroke Unit of the Hospital Germans Trias i Pujol, with experience on acute treatment, intravenous and endovascular reperfusion therapies, neuroimaging and neurosonology. Since 2020 she is the Director of the Catalan Stroke Plan, which aims to plan, implement and evaluate stroke care at territorial level. Within her areas of interest, she has been working during the last years on the pre-hospital organization of stroke care, leading the design, training and validation of the RACE scale, a pre-hospital scale to rapidly identify stroke patients with large vessel occlusion in the pre-hospital setting. She is co-Principal Investigator of the RACECAT trial, that compares transfer to the local center versus direct transfer to an endovascular center of patients with a suspicion of a large vessel occlusion. She has participated in multiple research trials, and has over 50 original articles and lectures in the field of cerebral vascular diseases.

I am Dr. Subash Phuyal. I grew up in Surunga, a small village in Nepal. I completed my MBBS from Nepal (2011), post-graduation (MD) in Radiology from PGIMER, Chandigarh (2014), and Doctorate of Medicine (DM) in Interventional Neuroradiology from AIIMS, New-Delhi, India (2019). Presently, I am a Neurointerventionist at UDM-National Institute of Neurological and Allied Sciences (only Biplane Cathlab in Nepal) and Grande International Hospital (one of the biggest hospitals of Nepal). I was fortunate to be involved in treating stroke patients with mechanical thrombectomy during my postgraduation, which was also the time when there was a revolution in stroke management.

Professor (Genetics), MD, PhD, DSc (Immunology/Allergology & Genetics). Scopus ID 7006540472; Researcher ID E-1373-2012; ORCID ID 0000-0002-5729-9846. Graduated from the Sechenov First Moscow Medical Institute, Moscow; 1975-1995: Research Centre for Medical Genetics, Moscow, immunogenetics and immunopharmacology. 1995 - 1998: StJude Research Hospital, Memphis, TN, visiting scholar, molecular pharmacology; 1998-2009 University of Nebraska Medical Center, Omaha, NE, Res. asst. professor, cancer immunology, immunoinformatics, vaccine studies. 2012-current: V.A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitation, Moscow, Russia, Head and Major Scientist, Laboratory of molecular mechanisms of critical illness. 2016, 2018: visiting scientist, Wistar Institute, Philadelphia, PA (Immunology). Current research interests: genetics and immunology of critical illness; genetic polymorphism in stroke and sepsis; prognostic biomarkers in stroke; immunomics of critical illness; myeloid-derived suppressor cells in cancer, healthcare-associated infection, and sepsis. Expert for EU Commission (H2020-MSCA-IF-2020), 2012-current: expert for Russian Academy of Sciences, Ministry of Science and Higher education of Russian Federation, Russian Scientific Foundation. Scientific Editor, General Reanimatology (Scopus, Q3). Society for Shock Studies in Russia (SSSR, member of IFSS), Executive Secretary.